# Wang Lei

Joined Fengrui Capital in 2015, focusing on investment in technology and medical care and in charge of the financial and legal department. Representative projects include Xingeyuan, Yanming Biotech, Changmugu Medical, Cayudi Biotech, Yinshi Robotics, Dingou Biotech, Nordson Chuanglian, Leao Medical, Novita, and Jiahua Yaorui. Before joining Fengrui Capital, he had more than 10 years of experience in management consulting for biomedical companies in the United States and multinational companies, commercialization of pharmaceutical and diagnostic companies, and as a technology partner in start-up companies. He holds an MBA in Healthcare from Boston University and a PhD in Physiology and Molecular Biology from the University of Notre Dame. 2025 was rated as "2024 Most Potential Female Direct Investment Fund Investors TOP" by the Fund of Funds Research Center, "S 2024 Female Investors" in ZeroIPO Entrepreneurship-Investment Circle, and was selected as "2025" by the Investor Network List of the 38 Best Female Investors", and won the "50 Outstanding Medical and Health Investors of the Year TOP" by CHC Medical Consulting & CITIC Securities (20, 2024, 50).

Joined Fengrui Capital in 2015, focusing on investment in technology and medical care and in charge of the financial and legal department. Representative projects include Xingeyuan, Yanming Biotech, Changmugu Medical, Cayudi Biotech, Yinshi Robotics, Dingou Biotech, Nordson Chuanglian, Leao Medical, Novita, and Jiahua Yaorui. Before joining Fengrui Capital, he had more than 10 years of experience in management consulting for biomedical companies in the United States and multinational companies, commercialization of pharmaceutical and diagnostic companies, and as a technology partner in start-up companies. He holds an MBA in Healthcare from Boston University and a PhD in Physiology and Molecular Biology from the University of Notre Dame. 2025 was rated as "2024 Most Potential Female Direct Investment Fund Investors TOP" by the Fund of Funds Research Center, "S 2024 Female Investors" in ZeroIPO Entrepreneurship-Investment Circle, and was selected as "2025" by the Investor Network List of the 38 Best Female Investors", and won the "50 Outstanding Medical and Health Investors of the Year TOP" by CHC Medical Consulting & CITIC Securities (20, 2024, 50).

Canonical: https://uniquebase.ai/people/UB-P3760
Stable identifier: UB-P3760
Snapshot captured: 2026-10-22T00:48:04.883Z
English updated: 2026-10-22T03:04:00.403Z

## Sources

- No source links are available for this profile.